Machine perfusion of thoracic organs.
暂无分享,去创建一个
Filip Rega | Steffen Rex | Dirk Van Raemdonck | F. Rega | S. Rex | Arne Neyrinck | A. Neyrinck | D. Van raemdonck
[1] K. Shadan,et al. Available online: , 2012 .
[2] S. Germscheid,et al. Ex vivo perfusion of the swine heart as a method for pre-transplant assessment , 2012, Perfusion.
[3] P. Sanchez,et al. Successful lung salvage by ex vivo reconditioning of neurogenic pulmonary edema: case report. , 2014, Transplantation proceedings.
[4] S. Toyooka,et al. Suppression of inflammatory cytokines during ex vivo lung perfusion with an adsorbent membrane. , 2010, The Annals of thoracic surgery.
[5] P. Corris,et al. The effect of ex vivo lung perfusion on microbial load in human donor lungs. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[6] D. Wishart,et al. Metabolic Profile of Ex Vivo Lung Perfusate Yields Biomarkers for Lung Transplant Outcomes , 2018, Annals of surgery.
[7] M. Mengel,et al. A Leukocyte Filter Does Not Provide Further Benefit During Ex Vivo Lung Perfusion , 2017, ASAIO journal.
[8] W. Wicomb,et al. Cardiac transplantation following storage of the donor heart by a portable hypothermic perfusion system. , 1984, The Annals of thoracic surgery.
[9] J. Dyck,et al. Negative pressure ventilation decreases inflammation and lung edema during normothermic ex-vivo lung perfusion. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[10] S. Russell,et al. Report from a consensus conference on primary graft dysfunction after cardiac transplantation. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[11] J. Fildes,et al. Clinical Outcome of Patients Transplanted with Marginal Donor Lungs via Ex Vivo Lung Perfusion Compared to Standard Lung Transplantation , 2015, Transplantation.
[12] B. Leskosek,et al. Ex vivo reconditioning of marginal donor lungs injured by acid aspiration. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[13] V. Ranieri,et al. Incidence and severity of primary graft dysfunction after lung transplantation using rejected grafts reconditioned with ex vivo lung perfusion. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[14] R. Fisk,et al. Ex vivo evaluation of stored lungs. , 1970, The Annals of thoracic surgery.
[15] G. Remuzzi,et al. Immunomodulatory effects of mesenchymal stromal cells in solid organ transplantation , 2010, Current opinion in organ transplantation.
[16] F. Rega,et al. Machine perfusion in organ transplantation: a tool for ex-vivo graft conditioning with mesenchymal stem cells? , 2013, Current opinion in organ transplantation.
[17] S. Keshavjee,et al. Report of the ISHLT Working Group on primary lung graft dysfunction Part IV: Prevention and treatment: A 2016 Consensus Group statement of the International Society for Heart and Lung Transplantation. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[18] L. Dembo,et al. Successful Heart Transplant after Ten Hours Out-of-body Time using the TransMedics Organ Care System. , 2015, Heart, lung & circulation.
[19] C. White,et al. Donor heart preservation: straight up, or on the rocks? , 2015, The Lancet.
[20] Alvaro Rojas-Pena,et al. Achieving 12 Hour Normothermic Ex Situ Heart Perfusion: An Experience of 40 Porcine Hearts , 2016, ASAIO journal.
[21] L. Lund,et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung And Heart-Lung Transplantation Report-2017; Focus Theme: Allograft ischemic time. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[22] Lars M. Mattison,et al. Prolonged EVLP Using OCS Lung: Cellular and Acellular Perfusates , 2017, Transplantation.
[23] P. Macdonald,et al. Adult heart transplantation with distant procurement and ex-vivo preservation of donor hearts after circulatory death: a case series , 2015, The Lancet.
[24] G. Verleden,et al. Immunoregulatory effects of multipotent adult progenitor cells in a porcine ex vivo lung perfusion model , 2017, Stem Cell Research & Therapy.
[25] S. Keshavjee,et al. Soluble Adhesion Molecules During Ex Vivo Lung Perfusion Are Associated With Posttransplant Primary Graft Dysfunction , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[26] W. Klepetko,et al. Standard donor lung procurement with normothermic ex vivo lung perfusion: A prospective randomized clinical trial. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[27] S. Large,et al. Resuscitating heart transplantation: the donation after circulatory determined death donor. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[28] W. Weder,et al. Ex vivo treatment with inhaled N-acetylcysteine in porcine lung transplantation. , 2017, The Journal of surgical research.
[29] J. Luketich,et al. Targeting Circulating Leukocytes and Pyroptosis During Ex Vivo Lung Perfusion Improves Lung Preservation , 2017, Transplantation.
[30] S. Khuri,et al. Continuous perfusion of donor hearts in the beating state extends preservation time and improves recovery of function. , 1998, The Journal of thoracic and cardiovascular surgery.
[31] B. Xiang,et al. A whole blood-based perfusate provides superior preservation of myocardial function during ex vivo heart perfusion. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[32] G. Dellgren,et al. Hemofiltration in ex vivo lung perfusion-a study in experimentally induced pulmonary edema. , 2016, The Journal of thoracic and cardiovascular surgery.
[33] Kristen M. Mackowick,et al. Current state of ex-vivo lung perfusion , 2016, Current opinion in organ transplantation.
[34] J. Madsen,et al. Mid and Long-Term Clinical Results of OCS Lung INSPIRE International Trial , 2016 .
[35] A. Neyrinck,et al. Can we make recovered donor lungs look brand-new again? , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[36] M. Matthay,et al. Concise Review: Mesenchymal Stem Cells for Acute Lung Injury: Role of Paracrine Soluble Factors , 2011, Stem cells.
[37] W. Wicomb,et al. Twenty-four-hour preservation of the pig heart by a portable hypothermic perfusion system. , 1982, Transplantation.
[38] S. Keshavjee,et al. Extracorporeal lung perfusion (ex-vivo lung perfusion) , 2016, Current opinion in organ transplantation.
[39] C. Salas,et al. 90 Clinical Lung Transplantation after Ex Vivo Evaluation of Uncontrolled Non Heart-Beating Donors Lungs: Initial Experience , 2011 .
[40] B. Xiang,et al. Physiologic Changes in the Heart Following Cessation of Mechanical Ventilation in a Porcine Model of Donation After Circulatory Death: Implications for Cardiac Transplantation , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[41] P. Johnsson,et al. Clinical transplantation of initially rejected donor lungs after reconditioning ex vivo. , 2009, The Annals of thoracic surgery.
[42] S. Keshavjee,et al. Advances in lung preservation. , 2013, The Surgical clinics of North America.
[43] M. Matthay,et al. Mesenchymal Stem (Stromal) Cells: Biology and Preclinical Evidence for Therapeutic Potential for Organ Dysfunction following Trauma or Sepsis , 2016 .
[44] F. Rosenfeldt,et al. Low-flow hypothermic crystalloid perfusion is superior to cold storage during prolonged heart preservation. , 2014, Transplantation proceedings.
[45] R. Hasan,et al. Innovations in cardiac transplantation , 2017, Current opinion in cardiology.
[46] J. Lally,et al. An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK. , 2016, Health technology assessment.
[47] P. Macdonald,et al. Ex-vivo Donor Heart Perfusion: Testing the Limits of Cardiac Resilience. , 2015, Heart, lung & circulation.
[48] W. Weder,et al. Successful lung transplantation after donor lung reconditioning with urokinase in ex vivo lung perfusion system. , 2014, The Annals of thoracic surgery.
[49] S. Keshavjee,et al. Ex-vivo lung perfusion: the model for the organ reconditioning hub , 2017, Current opinion in organ transplantation.
[50] K. English,et al. Allogeneic mesenchymal stem cells: Agents of immune modulation , 2011, Journal of cellular biochemistry.
[51] S. Steen,et al. Transplantation of lungs from non-heart-beating donors after functional assessment ex vivo. , 2003, The Annals of thoracic surgery.
[52] Marius Roman,et al. Comparison between cellular and acellular perfusates for ex vivo lung perfusion in a porcine model. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[53] Y. Dmitriev,et al. Preservation of the donor heart: from basic science to clinical studies. , 2015, Interactive cardiovascular and thoracic surgery.
[54] S. Keshavjee,et al. Extending the donor pool: rehabilitation of poor organs. , 2015, Thoracic surgery clinics.
[55] A. Fisher,et al. Ex vivo lung perfusion in clinical lung transplantation--state of the art. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[56] P. Macdonald,et al. Extracorporeal heart perfusion before heart transplantation: the heart in a box , 2016, Current opinion in organ transplantation.
[57] N. Fukushima. Current status and future aspects of ex vivo allograft perfusion for heart transplantation. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[58] S. Keshavjee,et al. Functional outcomes and quality of life after normothermic ex vivo lung perfusion lung transplantation. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[59] P. Vogt,et al. Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors. , 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[60] H. Møller-Sørensen,et al. First Danish experience with ex vivo lung perfusion of donor lungs before transplantation. , 2014, Danish medical journal.
[61] G. Oniscu,et al. Extending normothermic regional perfusion to the thorax in donors after circulatory death , 2017, Current opinion in organ transplantation.
[62] S. Steen,et al. Comparative outcome of double lung transplantation using conventional donor lungs and non-acceptable donor lungs reconditioned ex vivo. , 2011, Interactive cardiovascular and thoracic surgery.
[63] S. Keshavjee,et al. Extracorporeal lung perfusion , 2011, Current opinion in organ transplantation.
[64] S. Keshavjee,et al. Extension of donor lung preservation with hypothermic storage after normothermic ex vivo lung perfusion. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[65] Shaf Keshavjee,et al. A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[66] F. de Robertis,et al. Early outcomes of bilateral sequential single lung transplantation after ex-vivo lung evaluation and reconditioning. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[67] A. Poncelet,et al. Hypothermic continuous machine perfusion enables preservation of energy charge and functional recovery of heart grafts in an ex vivo model of donation following circulatory death. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[68] S. Steen,et al. Safe orthotopic transplantation of hearts harvested 24 hours after brain death and preserved for 24 hours , 2016, Scandinavian cardiovascular journal : SCJ.
[69] M. Weiss,et al. Mesenchymal stromal cell-derived extracellular vesicles attenuate lung ischemia-reperfusion injury and enhance reconditioning of donor lungs after circulatory death , 2017, Respiratory Research.
[70] V. Valero,et al. Association Between Prolonged Graft Ischemia and Primary Graft Failure or Survival Following Lung Transplantation. , 2015, JAMA surgery.
[71] F. de Robertis,et al. Evaluation of the organ care system in heart transplantation with an adverse donor/recipient profile. , 2014, The Annals of thoracic surgery.
[72] G. Warnecke. Ex Vivo Treatment. , 2016, Transplantation.
[73] G. Verleden,et al. Preemptive therapy with steroids but not macrolides improves gas exchange in caustic-injured donor lungs. , 2011, The Journal of surgical research.
[74] P. Jansz,et al. Increasing the Tolerance of DCD Hearts to Warm Ischemia by Pharmacological Postconditioning , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[75] J. Davies,et al. Mesenchymal stem cell treatment is associated with decreased perfusate concentration of interleukin-8 during ex vivo perfusion of donor lungs after 18-hour preservation. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[76] S. Vesconi,et al. Successful Transplantation of Lungs From an Uncontrolled Donor After Circulatory Death Preserved In Situ by Alveolar Recruitment Maneuvers and Assessed by Ex Vivo Lung Perfusion , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[77] G. Tenderich,et al. 10: Prospective multi-center European trial to evaluate the safety and performance of the Organ Care System for heart transplants (PROTECT) , 2007 .
[78] Utilization of the Organ Care System Lung for the assessment of lungs from a donor after cardiac death (DCD) before bilateral transplantation , 2015, Perfusion.
[79] E. Ashley,et al. Functional assessment and transplantation of the donor heart after circulatory death. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[80] L. Santambrogio,et al. Ex vivo lung perfusion to improve donor lung function and increase the number of organs available for transplantation , 2014, Transplant international : official journal of the European Society for Organ Transplantation.
[81] S. Keshavjee,et al. α1-Anti-trypsin improves function of porcine donor lungs during ex-vivo lung perfusion. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[82] H. Ott,et al. Injury-specific ex vivo treatment of the donor lung: pulmonary thrombolysis followed by successful lung transplantation. , 2013, American journal of respiratory and critical care medicine.
[83] Marcelo Cypel,et al. Experience with the first 50 ex vivo lung perfusions in clinical transplantation. , 2012, The Journal of thoracic and cardiovascular surgery.
[84] S. Keshavjee,et al. The clinical potential of ex vivo lung perfusion , 2012, Expert review of respiratory medicine.
[85] N. Perico,et al. Mesenchymal stromal cells to promote solid organ transplantation tolerance , 2013, Current opinion in organ transplantation.
[86] G. Dellgren,et al. Comparison of two strategies for ex vivo lung perfusion. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[87] F. D'Ovidio,et al. Ex-vivo lung perfusion , 2012, Current opinion in organ transplantation.
[88] S. Keshavjee,et al. Normothermic Ex Vivo Perfusion Prevents Lung Injury Compared to Extended Cold Preservation for Transplantation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[89] S. Keshavjee,et al. Outcomes after transplantation of lungs preserved for more than 12 h: a retrospective study. , 2017, The Lancet. Respiratory medicine.
[90] D. Valdivia,et al. Clinical lung transplantation from uncontrolled non-heart-beating donors revisited. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[91] B. Meyns,et al. Current preservation technology and future prospects of thoracic organs. Part 2: heart , 2010, Current opinion in organ transplantation.
[92] G. Dellgren,et al. Transplantation after ex vivo lung perfusion: A midterm follow-up. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[93] G. Verleden,et al. A porcine ex vivo lung perfusion model with maximal argon exposure to attenuate ischemia-reperfusion injury , 2017, Medical gas research.
[94] A. Ardehali,et al. 19: Serum Lactate Is a Highly Sensitive and Specific Predictor of Post Cardiac Transplant Outcomes Using the Organ Care System , 2009 .
[95] B. Griffith,et al. The NOVEL Lung Trial One-Year Outcomes , 2014 .
[96] A. Haverich,et al. Normothermic perfusion of donor lungs for preservation and assessment with the Organ Care System Lung before bilateral transplantation: a pilot study of 12 patients , 2012, The Lancet.
[97] D. Foley,et al. Safety of Antithymocyte Globulin in Patients Undergoing Liver Transplantation With Livers From Donation After Circulatory Death Donors , 2019, The Annals of pharmacotherapy.
[98] A. Ardehali,et al. Normothermic donor heart perfusion: current clinical experience and the future , 2015, Transplant international : official journal of the European Society for Organ Transplantation.
[99] P. Dartevelle,et al. Graft ischemic time and outcome of lung transplantation: a multicenter analysis. , 2005, American journal of respiratory and critical care medicine.
[100] T. Frauenfelder,et al. Cytokine filtration modulates pulmonary metabolism and edema formation during ex vivo lung perfusion. , 2016, The Journal of Heart and Lung Transplantation.
[101] A. Rose,et al. Forty-eight hours hypothermic perfusion storage of pig and baboon hearts. , 1986, The Journal of surgical research.
[102] L. Liaudet,et al. Pharmacological Reconditioning of Marginal Donor Rat Lungs Using Inhibitors of Peroxynitrite and Poly (ADP-ribose) Polymerase During Ex Vivo Lung Perfusion , 2016, Transplantation.
[103] A. Simon,et al. Ex vivo heart perfusion after cardiocirculatory death; a porcine model. , 2015, The Journal of surgical research.
[104] B. Xiang,et al. Hearts From DCD Donors Display Acceptable Biventricular Function After Heart Transplantation in Pigs , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[105] S. Keshavjee,et al. The role of the endothelin-1 pathway as a biomarker for donor lung assessment in clinical ex vivo lung perfusion. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[106] J. Luketich,et al. Optimal ex vivo lung perfusion techniques with oxygenated perfusate. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[107] J. Luc,et al. Lung transplantation from donors after circulatory death using portable ex vivo lung perfusion. , 2015, Canadian respiratory journal.
[108] Christoph Benk,et al. Ex vivo perfusion of the heart with the use of the Organ Care System. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[109] P. Jansz,et al. Normothermic Ex Vivo Perfusion Provides Superior Organ Preservation and Enables Viability Assessment of Hearts From DCD Donors , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[110] G. Verleden,et al. Radiological Analysis of Unused Donor Lungs: A Tool to Improve Donor Acceptance for Transplantation? , 2017, American Journal of Transplantation.
[111] S. Keshavjee,et al. Importance of left atrial pressure during ex vivo lung perfusion. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[112] N. Perico,et al. Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT). , 2010, Transplantation.
[113] W. S. Ring,et al. Perfusion preservation versus static preservation for cardiac transplantation: effects on myocardial function and metabolism. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[114] Michael John Smith,et al. The OCS Lung EXPAND International Trial Interim Results , 2016 .
[115] G. Lang,et al. Clinical Ex Vivo Lung Perfusion—Pushing the Limits , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[116] P. Macdonald,et al. Heart transplantation from donation after circulatory death donors. , 2015, Transplantation.
[117] Marcelo Cypel,et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. , 2011, The New England journal of medicine.
[118] S. Keshavjee,et al. Lung Transplantation With Donation After Circulatory Determination of Death Donors and the Impact of Ex Vivo Lung Perfusion , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[119] E. Proctor,et al. Preservation of Isolated Heart for 72 Hours , 1968, British medical journal.
[120] J. Kobashigawa,et al. Intermediate outcomes with ex-vivo allograft perfusion for heart transplantation. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[121] Amadou K. S. Camara,et al. Low-flow perfusion of guinea pig isolated hearts with 26 degrees C air-saturated Lifor solution for 20 hours preserves function and metabolism. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[122] W. Weimar,et al. Mesenchymal stem cells: application for solid-organ transplantation , 2012, Current opinion in organ transplantation.
[123] V. Puri,et al. Lung transplantation from donation after cardiocirculatory death: a systematic review and meta-analysis. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[124] B. Griffith,et al. Heart preservation using continuous ex vivo perfusion improves viability and functional recovery. , 2007, Circulation journal : official journal of the Japanese Circulation Society.
[125] F. Mohr,et al. Functional, metabolic, and morphological aspects of continuous, normothermic heart preservation: effects of different preparation and perfusion techniques. , 2009, Tissue engineering. Part C, Methods.
[126] M. Stoler,et al. Lungs donated after circulatory death and prolonged warm ischemia are transplanted successfully after enhanced ex vivo lung perfusion using adenosine A2B receptor antagonism , 2017, The Journal of thoracic and cardiovascular surgery.
[127] Bartley P Griffith,et al. State of art: clinical ex vivo lung perfusion: rationale, current status, and future directions. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[128] S. Keshavjee,et al. Ex Vivo Perfusion Treatment of Infection in Human Donor Lungs , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[129] M. Ochs,et al. Evaluating acellular versus cellular perfusate composition during prolonged ex vivo lung perfusion after initial cold ischaemia for 24 hours , 2016, Transplant international : official journal of the European Society for Organ Transplantation.
[130] G. Tenderich,et al. Normothermic ex vivo allograft blood perfusion in clinical heart transplantation. , 2014, The heart surgery forum.
[131] Simi Ali,et al. The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[132] P. Dartevelle,et al. Lung transplantation from initially rejected donors after ex vivo lung reconditioning: the French experience. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[133] W. Weder,et al. Ex vivo administration of trimetazidine improves post-transplant lung function in pig model† , 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[134] S. Steen,et al. Transplantation of lungs from a non-heart-beating donor , 2001, The Lancet.
[135] G. Verleden,et al. A retrospective database analysis to evaluate the potential of ex vivo lung perfusion to recruit declined lung donors , 2017, Transplant international : official journal of the European Society for Organ Transplantation.
[136] G. Snell,et al. How can we improve the quality of transplantable lungs? , 2016, Expert review of respiratory medicine.
[137] G. Verleden,et al. Short- and Long-term Outcomes After Lung Transplantation From Circulatory-Dead Donors: A Single-Center Experience , 2017, Transplantation.
[138] Pascal Leprince,et al. Ex-vivo perfusion of donor hearts for human heart transplantation (PROCEED II): a prospective, open-label, multicentre, randomised non-inferiority trial , 2015, The Lancet.
[139] L. M. Anderson,et al. Preservation of donor hearts using hypothermic oxygenated perfusion. , 2014, Annals of transplantation.
[140] Marius Roman,et al. Ex vivo lung perfusion: a comprehensive review of the development and exploration of future trends. , 2013, Transplantation.
[141] G. Dellgren,et al. Early results in transplantation of initially rejected donor lungs after ex vivo lung perfusion: a case-control study. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[142] P. Macdonald,et al. Donation after circulatory death heart transplantation , 2017, Current opinion in organ transplantation.
[143] P. White,et al. Cardiac recovery in a human non-heart-beating donor after extracorporeal perfusion: source for human heart donation? , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[144] V. Puri,et al. International Society for Heart and Lung Transplantation Donation After Circulatory Death Registry Report. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[145] G. Dellgren,et al. Transplantation of initially rejected donor lungs after ex vivo lung perfusion. , 2012, The Journal of thoracic and cardiovascular surgery.
[146] F. de Robertis,et al. Utilization of the organ care system for bilateral lung transplantation: preliminary results of a comparative study. , 2016, Interactive cardiovascular and thoracic surgery.
[147] Triin Major,et al. Altered Immunogenicity of Donor Lungs via Removal of Passenger Leukocytes Using Ex Vivo Lung Perfusion , 2015, American Journal of Transplantation.
[148] L. Lund,et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[149] J. Pirenne. Time to think out of the (ice) box. , 2010, Current opinion in organ transplantation.
[150] M. Rojas,et al. Ex Vivo Lung Perfusion: Past, Present, and Future , 2017, ASAIO journal.
[151] Arthur S Slutsky,et al. Functional Repair of Human Donor Lungs by IL-10 Gene Therapy , 2009, Science Translational Medicine.
[152] P. Bonnette,et al. Real-Time Computed Tomography Highlights Pulmonary Parenchymal Evolution During Ex Vivo Lung Reconditioning. , 2017, The Annals of thoracic surgery.
[153] M. Hannan,et al. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[154] Stefan Fischer,et al. Technique for prolonged normothermic ex vivo lung perfusion. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[155] S. Keshavjee,et al. Update on donor assessment, resuscitation, and acceptance criteria, including novel techniques--non-heart-beating donor lung retrieval and ex vivo donor lung perfusion. , 2009, Thoracic surgery clinics.
[156] M. Hoogduijn,et al. The impact of mesenchymal stem cell therapy in transplant rejection and tolerance , 2012, Current opinion in organ transplantation.
[157] H. Date,et al. Bronchodilator Inhalation During Ex Vivo Lung Perfusion Improves Posttransplant Graft Function After Warm Ischemia. , 2017, The Annals of thoracic surgery.
[158] B. Xiang,et al. A cardioprotective preservation strategy employing ex vivo heart perfusion facilitates successful transplant of donor hearts after cardiocirculatory death. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[159] B. Griffith,et al. Autoperfusion of the heart and lungs for preservation during distant procurement. , 1987, The Journal of thoracic and cardiovascular surgery.